Eli Lilly | LLY - EPS Earnings Per Share


Eli Lilly reported $8.55 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 9.46 7.02 Oct/29
FY2026Q2 Jun/2026 8.82 6.31 Aug/05
FY2026Q1 Mar/2026 8.55 7.25 3.34 Apr/30
FY2025Q4 Dec/2025 7.54 7.16 5.32 Feb/04
FY2025Q3 Sep/2025 7.02 6.36 1.18 Oct/30




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.31 0.16 Jun/2026
ALKERMES USD -0.4 0.69 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026